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R E S U M E N
Fuerza muscular, densidad ósea y composición corporal de una mujer con lupus eritema-
toso sistémico sometido a un programa de entrenamiento de resistencia
Introducción. La actividad física puede proveer beneficios a largo plazo para el lupus eritematoso sistémico 
(LES).
Objetivo. Esta investigación busca demostrar los efectos del entrenamiento de resistencia progresiva sobre: 
la fuerza muscular, la densidad mineral ósea (DMO) y la composición corporal de una mujer premenopáu-
sica con LES sometido a tratamiento con glucocorticoides.
Materiales y Métodos. Una mujer con 43 años de edad, afrodescendiente, premenopáusica con LES sin 
gravedad y baja DmO fue sometida a programa de 6 meses con 3 ciclos bimestrales de 70, 80 y 90% de in-
tensidad, considerando un test de fuerza máxima de 10 repeticiones máximas. Se utilizó, para medir la 
DMO, la absorptiometría de doble energía con rayos X, evaluando los T-scores, el índice de masa corporal y 
la fluorescencia indirecta para medir los anticuerpos antinucleares. Para la comparación de medias de va-
riables, se utilizó el test de la T de Student.
Resultados. Se observó mejora en la fuerza, incluyendo (Δ% = 50%, p < 0,001) en la prensa de piernas de 45°, 
(Δ% = 15%, p = 0,003) en la extensión de la rodilla, como el mantenimiento de la DMO de la columna lumbar 
L2-L4 (Δ% = 0,031%, p = 0,46) y trocánter (Δ% = 0,037%, p = 0,31), además de mantener el índice de masa 
corporal (Δ% = -0,8, p = 0,54).
Conclusión. En este estudio de caso, se observaron efectos positivos sobre la fuerza muscular e indicios de 
mantenimiento de la DMO y de la composición corporal de una mujer con LES en tratamiento con glucocor-
ticoides.
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A B S T R A C T
Introduction. Physical activity can provide long-term benefits for systemic lupus erythematosus (SLE).
Objective. This study sought to demonstrate the effects of progressive resistance training on the muscular 
strength, bone mineral density (BMD) and body composition of pre-menopausal women with SLE 
undergoing glucocorticoid (GC) treatment.
Materials and Methods. This is the case report of a 43-year-old African-South American premenopausal 
woman with non-extensive SLE and low bone density. A six-month program with three bimonthly cycles of 
70%, 80%, and 90% intensity according to the 10 maximum-repetition test was used. Dual-energy X-ray 
absorptiometry (DXA) was used to measure the BMD, T-scores and body composition, and indirect 
fluorescence was used to measure the levels of antinuclear antibodies. Student’s t-test was used.
Results. Statistical improvement was noted in all strength exercises, including the 45° leg press (Δ%=+50%, 
p<0.001) and knee extension (Δ%=+15%, p=0.003) to maintain the BMD of the L2-L4 lumbar (Δ%=+0.031%; p= 
0.46) as well as the trochanter (Δ%=+0.037%; p=0.31) and BMI (Δ%=-0.8, p=0.54).
Conclusion. In this case study, the presented methodology had a positive effect on strength and contributed 
to the maintenance of BMD and body composition in a woman with SLE undergoing GC treatment.
© 2012 Revista Andaluza de Medicina del Deporte.
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Introduction
Systemic lupus erythematosus (SLE) is a chronic inflammatory immune 
system disease of unknown etiology in which antibodies and 
immune complexes injure different cells and tissues1. The risk for SLE 
development has a genetic component that is often associated with 
environmental factors and lifestyle choices, such as solar ‚ radiation 
exposure, stress, sedentary behavior, and the use of certain medications, 
that tend to trigger disease manifestation2.
SLE can occur in all ethnic and age groups, and it is more severe in 
children and young adults despite being more frequently diagnosed 
in women of reproductive age3. The SLE diagnosis was established by the 
American College of Rheumatology in 1982 and revised in 19974, and it 
is based on the presence of at least four of eleven criteria, including 
discoid lesions (erythematous), photosensitivity, arthritis (non-erosive 
with pain, swelling, and joint effusion) and abnormal titers of antinuclear 
antibodies (ANA)4. Although there are many criteria related to the SLE 
diagnosis, the positive result of ANA revealed by immunofluorescence 
may be indicative of the diagnosis5.
For the treatment of SLE, glucocorticoids (GC) are among the drugs 
used most commonly because they have an anti-inflammatory effect 
that reduces pain and immunosuppression, which inhibits the synthesis 
of autoantibodies6. However, the main adverse effects resulting from the 
prolonged use of GC include a reduction in bone mineral density (BMD)6. 
In addition, the sarcopenia is another effect that reduces muscle mass 
and consequently the strength with negative consequences for the 
functional autonomy, with an increased risk of falls7.
Most existent studies have investigated aerobic capacity8-11, and few 
studies have focused on the effects of resistance training (RT) in older 
women with SLE11.
The studies suggest that physical activity can provide long-term 
benefits for SLE8,10 and that measures aimed at improvement through 
physical exercise can contribute to overall functional performance, 
fatigability, social stress and quality of life in individuals affected by 
diseases that result in bone demineralization by helping to control BMD 
loss8,9,11.
Among the different types of physical activities, RT has demonstrated 
effectiveness in treating women with low BMD through effective control 
of the volume and intensity of loads to favor strength and BMD 
increases12-14. In addition, the RT can protect against sarcopenia. This 
process produces important and severe effects on the functional 
autonomy and quality of life in older women and is the most frequent 
cause of discapacity, dependency and increased or morbi-mortality7. 
However, few studies related to SLE and physical activity, especially 
regarding RT, have been presented in the literature8. Thus, this case 
study aimed to demonstrate the effects of progressive RT on BMD and 
muscle strength in premenopausal women with SLE treated with GC.
Materials and methods
The individual in this intra-subject study was a 43-year-old 
premenopausal female volunteer with normal ovulation, who was 155 
cm in height and weighed 52 kg. The subject did not engage in any 
physical activity for four months, even though she used to practice RT 
and walked regularly before this period. She is an African-South 
American woman, whose disease was detected 15 years ago. However, 
she did not have extensive SLE, nor was her system compromised by 
lupus. In addition, the volunteer had a history of chronic arthritis with 
pain, edema and photosensitivity. The patient also presented ANA 1:160 
(fine speckled), which can suggest the presence of positive anti-SSa/Ro. 
The fact that the patient presented negative anti-DNA and anti-Sm 
(Smith) does not exclude the diagnosis of lupus, as the patient did not 
present signs or symptoms of dry mouth syndrome, which rules out the 
diagnosis of Sjögren’s syndrome.
The volunteer had normal functional activity and carried out her 
daily work activities. Her treatment, prescribed by the physician in 
charge, was based on the daily use of 7.5 mg/day of GC and 6 mg/kg/day 
of hydroxychloroquine sulfate; the dose was adjusted as necessary 
throughout the study period. In addition, the volunteer was not taking 
medication for anti-conception for more than 20 years and was also not 
taking medications such as bisphosphonates for low BMD. However, less 
than 5 years prior to the study, the volunteer had begun taking vitamin 
D+/day (400 UI). This regimen was continued throughout the study 
period.
The volunteer agreed to the presentation of her case for scientific 
research purposes by signing an informed consent form. The project was 
approved by the research ethics committee at the University Castelo 
Branco-RJ COMEP / PROCIMH under proposal number 0171/2008.
The osteopenia diagnosis was obtained using a dual-energy X-ray 
absorptiometry (DXA) machine manufactured by Lunar® (USA; DPX 
class with a 750-μA current, calibrated daily). A medical specialist 
performed the examination with the volunteer in a supine position on 
the equipment table with her legs supported at an immobile 30o angle. 
Scanning was performed in the region of the right femur and lumbar 
spine. The variables provided by DXA were body composition (height, 
mass and BMI), BMD (g/cm2) and negative T-scores for the lumbar spine 
L2-L4, femoral neck, and trochanter.
Based on the DXA, the BMD of the lumbar L2-L4 was 0.904 g/cm2 with 
a T-score of -2.46 standard deviations (SD). For the femoral neck, the 
BMD was 0.764 g/cm2 with a T-score of -1.80 SD; for the trochanter, 
the BMD was 0.677 g/cm2 with a T-score = -1.03 SD.
Because the subject had already practiced RT and did not present 
swollen joints or muscle soreness, the RT followed the timeline proposed 
by Borba-Pinheiro et al12,13 using bimonthly cycles, with the 10 maximum 
repetition test (10RM) performed at progressive intensities. The subject 
performed the 10 RM test at the beginning and the end of each cycle 
over the six-month training period (table 1). Each training session lasted 
sixty minutes and was performed three times per week on alternate 
days.
The volunteer performed nine exercises: the 45° leg press, knee 
extension, hip adduction, plantar flexion, gluts, squats, elbow flexion, 
elbow extension, and shoulder adduction. The equipment used for the 
training was manufactured by Pró-Physical® (Brazil).
Results
At the end of the six-month period, new evaluations were conducted, 
and the volunteer demonstrated maintenance of the BMD and T-scores. 
The absolute percentage difference was calculated by subtracting the 
initial test from the post-test [Δ% = post-test – pre-test]. Then, Student’s 
t-test for BMD variables was used, as shown in table 2.
Table 3 presents the percentage improvements in muscle strength 
observed throughout the progressive load increase utilized in the three 
10RM tests.
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As to the relationship between SLE and physical activity, there are 
few reports addressing the effects. However, Ayan and Martin8 suggest 
that physical exercise can improve cardiovascular fitness, reduce 
metabolic abnormalities or fatigue and consequently contribute to an 
improved quality of life for individuals with this disease. The study 
performed by Carvalho et al9 reinforces this hypothesis because it 
reported a significant improvement in exercise tolerance, aerobic 
capacity, quality of life and depression symptoms after the completion 
of a supervised cardiovascular training program for patients with SLE.
In another study using two groups of volunteers with SLE, one 
performing aerobic training and the other performing strength training 
with 70-80% of the maximum load with 2–3 sets of 10 repetitions at 
three weekly 50-minute sessions, the exercises performed by both 
groups were considered safe and did not aggravate the symptoms of SLE 
over a period of eight months11. Individuals from both groups showed 
improvements in fatigue, functional capacity, cardiovascular fitness, and 
muscle strength11. In this same study, an increase in bone turnover was 
noticed; however, the BMD remained unchanged in both groups.
Our work revealed that during the study period, there was an 
improvement in the levels of muscular strength and BMD maintenance 
in the volunteer. These results suggest an alternative methodology 
based on RT to aid in the treatment of this disease, because the approach 
described here could also be used for prevention and treatment 
strategies that protect against sarcopenia7. A recent review reinforces 
the findings of this study, suggesting that physical activity may have 
direct effects on reducing the level of systemic inflammation in chronic 
autoimmune diseases15.
In this review, no adverse effects due to exercise were found in 
patients with autoimmune disease. The fact that no adverse effects were 
observed can be explained by the fact that the induction of stress caused 
by exercise may provide physiological function alterations in the 
immune system that can increase the associated defense mechanisms15.
Another study showed that an increase in body composition may be 
associated with osteopenia and sarcopenia in women with lupus16. This 
Discussion
The results achieved in this case report directly demonstrate the 
percentage increase of muscle strength in all of the performed exercises 
and the maintenance of the BMD of the lumbar L2-L4 and greater 
trochanter, although the volunteer used GC, which promotes a reduction 
in BMD. The low BMD of the volunteer may be attributed to the daily use 
of GC for the control of articular pain6.
In a similar studies, Borba-Pinheiro et al12,13 report that RT planned 
over a 12-month period for post-menopausal women, consisting of 
three weekly sessions and different bimonthly intensities, was effective 
for increasing muscle strength and the BMD of the lumbar L2-L4, femoral 
neck, and greater trochanter of the volunteers compared with those 
engaged in other activities and the control group.
Borba-Pinheiro et al12,13 emphasize that effective gains and the 
maintenance of muscle strength and BMD require periodized resistance 
training, which is corroborated by other studies13,14. In addition to the 
load test, the training program is based on individual biology in terms 
of the selection of exercises and the use of interdependent volumes and 
intensities to establish the number of exercises, sets, repetitions, 
breaks, weekly sessions and intensities that would serve each individual 
best4.
Table 1
Periodization of Resistance Training
Six months
Bi-months – Cycle 1 Bi-months – Cycle 2 Bi-months – Cycle 3
Intensity – 70% Intensity – 80% Intensity – 90%
9 exercises 9 exercises 9 exercises
3 sessions 3 sessions 3 sessions
15 – 20 repetitions 8 – 10 repetitions 5 – 7 repetitions
VME – Moderate VME – Maximum VME – Slow
Interval sessions – 40 sec Interval sessions – 60 sec Interval sessions – 60 sec
Interval exercises – 60 sec Interval exercises – 60 sec Interval exercises – 60 sec
VME: Velocity of movement execution. Borba-Pinheiro et al12,13.
Table 2
Study Variables
Variables Pre-test Post-test ∆% p-value
Mass (kg) 52.0 50.0 –2.0 0.52*
Height (cm) 155.0 155.0 0.0 1.00*
BMI (kg/m2) 21.6 20.8 –0.8 0.54*
BMD Neck of the femur (g/cm2) 0.764 0.754 –0.01 0.80*
BMD Trochanter (g/cm2) 0.677 0.711 0.03 0.31* 
BMD Lumbar L2-L4 (g/cm2) 0.904 0.934 0.03 0.46*
T score Neck of the Femur (SD) –1.8 –1.88 0.08 1.00*
T score Trochanter (SD) –1.03 –0.69 0.34 1.00*
T score L2-L4 (SD) –2.46 –2.22 0.24 1.00*
BMD: Bone Mineral Density; BMI: Body Mass Index; (*): Student’s t-test.
Table 3
Strength Exercises-Variables
Exercises (kg) Pre Test Post 1 Post 2 Post 3 ∆% Post 1-Pre Test ∆% Post 2-Post 1 ∆% Post 3-Post 2 ∆% Post 3-Pre Test
Leg press at 45° 160 182 196 210 22 14 14 50*
Knee extension  35  40  45  50  5  5  5 15*
Hip adduction  40  45  50  55  5  5  5 15*
Plantar flexion  45  50  60  65  5 10  5 20*
Squats  30  35  40  45  5  5  5 15*
Gluts  45  55  60  65 10  5  5 20*
Elbow flexion   4   5   6   6  1  1  0  2*
Elbow extension  30  35  35  40  5  0  5 10*
Shoulder adduction  25  30  35  40  5  5  5 15*
∆%: Post-test-Test; (*): p<0.05 by Student’s t-test.
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information confirms the importance of the present study because it 
can minimize the effects caused by disease through the possible 
maintenance of weight, body mass index and bone density with 
increasing muscle strength and, consequently, the control of sarcopenia, 
which is corroborated by other studies13-15.
This report suggests that the progressive RT associated with drug 
therapy can minimize the symptomatic autoimmune effects of SLE. In 
addition to increasing muscle strength, the control of BMD and can 
maximize these results in favor of a better quality of life for the volunteer. 
However, this case study also demonstrates the need for new studies of 
experimental and control groups to verify the effects of RT associated 
with the use of medication for SLE.
Conclusion
In this case study, the presented methodology had a positive effect on 
strength, and it may contribute to the maintenance of BMD and the 
body composition of women without extensive SLE who are required to 
undergo GC treatment.
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